OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments
Stephen R. Marder, Daniel Umbricht
Schizophrenia Research (2023) Vol. 258, pp. 71-77
Open Access | Times Cited: 42
Stephen R. Marder, Daniel Umbricht
Schizophrenia Research (2023) Vol. 258, pp. 71-77
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials
William P. Horan, Steven D. Targum, Amy Claxton, et al.
Schizophrenia Research (2024) Vol. 274, pp. 57-65
Open Access | Times Cited: 16
William P. Horan, Steven D. Targum, Amy Claxton, et al.
Schizophrenia Research (2024) Vol. 274, pp. 57-65
Open Access | Times Cited: 16
Dissociative psychosis or dissociative schizophrenia? Comparison of two phenomena
Mahir Akbudak, Hasan Belli, Hasan Gökçay, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Mahir Akbudak, Hasan Belli, Hasan Gökçay, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
The Association of Redox Regulatory Drug Target Genes with Psychiatric Disorders: A Mendelian Randomization Study
Zhe Lu, Yang Yang, Guorui Zhao, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 398-398
Open Access | Times Cited: 5
Zhe Lu, Yang Yang, Guorui Zhao, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 398-398
Open Access | Times Cited: 5
Avolition Characterizes the Chronic Fatigue Experienced in Quiescent Inflammatory Bowel Disease
Tristan Gabriel, Margherita Boltri, Mathilde Barrau, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 125-125
Open Access
Tristan Gabriel, Margherita Boltri, Mathilde Barrau, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 125-125
Open Access
Comprehensive Insights into Schizophrenia Causes Treatments and Prevention
Chang Shu
Theoretical and Natural Science (2025) Vol. 89, Iss. 1, pp. 57-63
Closed Access
Chang Shu
Theoretical and Natural Science (2025) Vol. 89, Iss. 1, pp. 57-63
Closed Access
Probabalistic reinforcement learning impairments predict negative symptom severity and risk for conversion in youth at clinical high-risk for psychosis
Lauren Luther, Ian M. Raugh, Gregory P. Strauss
Psychological Medicine (2025) Vol. 55
Closed Access
Lauren Luther, Ian M. Raugh, Gregory P. Strauss
Psychological Medicine (2025) Vol. 55
Closed Access
Therapeutic efficacy of transcranial direct current stimulation in treating auditory hallucinations in schizophrenia: A meta-analysis
S Zou, Jin-Nan Shi
World Journal of Psychiatry (2025) Vol. 15, Iss. 3
Closed Access
S Zou, Jin-Nan Shi
World Journal of Psychiatry (2025) Vol. 15, Iss. 3
Closed Access
Multivariate deep phenotyping reveals behavioral correlates of non-restorative sleep in 22q11.2 Deletion Syndrome
Natacha Reich, Andrea Imparato, Jacinthe Cataldi, et al.
Psychiatry Research (2025) Vol. 347, pp. 116423-116423
Open Access
Natacha Reich, Andrea Imparato, Jacinthe Cataldi, et al.
Psychiatry Research (2025) Vol. 347, pp. 116423-116423
Open Access
Multi-feature fusion RFE random forest for schizophrenia classification and treatment response prediction
Chang Wang, Rui Zhang, Jiyuan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Chang Wang, Rui Zhang, Jiyuan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Effects of Sulforaphane on Negative Symptoms and Cognitive Impairments in chronic Schizophrenia patients: A Randomized Double-Blind Trial
Haiyu Chen, Jinjun Lu, Tianxiang Zou, et al.
Journal of Psychiatric Research (2025)
Closed Access
Haiyu Chen, Jinjun Lu, Tianxiang Zou, et al.
Journal of Psychiatric Research (2025)
Closed Access
Dynamic modular dysregulation in multilayer networks underlies cognitive and clinical deficits in first-episode schizophrenia
Xinyi Hu, Xiangyun Long, Jiaxin Wu, et al.
Neuroscience (2025)
Closed Access
Xinyi Hu, Xiangyun Long, Jiaxin Wu, et al.
Neuroscience (2025)
Closed Access
Exploratory analysis of the relationship between striatal connectivity and apathy during phosphodiesterase 10 inhibition in schizophrenia: findings from a randomized crossover trial
Wolfgang Omlor, Giacomo Cecere, Gao-Yang Huang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Wolfgang Omlor, Giacomo Cecere, Gao-Yang Huang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Association of the Characteristics of Brain Magnetic Resonance Imaging with Genes Related to Disease Onset in Schizophrenia Patients
Jennifer S Lin, Bo Wang, Shaoguang Chen, et al.
SLAS TECHNOLOGY (2025), pp. 100281-100281
Open Access
Jennifer S Lin, Bo Wang, Shaoguang Chen, et al.
SLAS TECHNOLOGY (2025), pp. 100281-100281
Open Access
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative Symptoms
Dragana Bugarski‐Kirola, I-Yuan Liu, Celso Arango, et al.
Schizophrenia Bulletin (2025)
Open Access
Dragana Bugarski‐Kirola, I-Yuan Liu, Celso Arango, et al.
Schizophrenia Bulletin (2025)
Open Access
Factors Affecting Negative Symptoms in Schizophrenia and Their Relationship with Anxiety and Depression
Gang Zeng, Rongyu Liang, Lingxian Xiao, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 229-240
Open Access
Gang Zeng, Rongyu Liang, Lingxian Xiao, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 229-240
Open Access
Network analysis of clinical features in patients with treatment-resistant schizophrenia
Wei Li, Jing Zhao, Na Hu, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Wei Li, Jing Zhao, Na Hu, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia
Haidong Yang, Ruijie Peng, Man Yang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Haidong Yang, Ruijie Peng, Man Yang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms
Yihuan Chen, Huan Yu, Fen Xue, et al.
Brain and Behavior (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 3
Yihuan Chen, Huan Yu, Fen Xue, et al.
Brain and Behavior (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 3
More than just a number: the gut microbiota and brain function across the extremes of life
Nathan D. Nuzum, Clara Deady, Sarah Kittel‐Schneider, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Nathan D. Nuzum, Clara Deady, Sarah Kittel‐Schneider, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Crocus sativus (saffron) adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled trial
Siamand Mazhar, Ahmad Shamabadi, Kimia Kazemzadeh, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 2
Siamand Mazhar, Ahmad Shamabadi, Kimia Kazemzadeh, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 2
Kognitive Beeinträchtigung in Zusammenhang mit Schizophrenie (CIAS): Diagnostik und Therapie
Gabriele Sachs, Andreas Erfurth
psychopraxis neuropraxis (2024) Vol. 27, Iss. 2, pp. 74-80
Open Access | Times Cited: 1
Gabriele Sachs, Andreas Erfurth
psychopraxis neuropraxis (2024) Vol. 27, Iss. 2, pp. 74-80
Open Access | Times Cited: 1
Esquizofrenia: manifestações clínicas e as principais comorbidades, uma revisão sistemática
Pedro Orsi, Matheus Augusto Luqui Lazzarin, Júlia Sammour, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 2, pp. e69158-e69158
Open Access | Times Cited: 1
Pedro Orsi, Matheus Augusto Luqui Lazzarin, Júlia Sammour, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 2, pp. e69158-e69158
Open Access | Times Cited: 1
Inhibition of striatal indirect pathway during second postnatal week leads to long-lasting deficits in motivated behavior
Pedro R. Olivetti, Arturo Torres-Herraez, Meghan E Gallo, et al.
Neuropsychopharmacology (2024) Vol. 50, Iss. 4, pp. 651-661
Closed Access | Times Cited: 1
Pedro R. Olivetti, Arturo Torres-Herraez, Meghan E Gallo, et al.
Neuropsychopharmacology (2024) Vol. 50, Iss. 4, pp. 651-661
Closed Access | Times Cited: 1
Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms
David G. Daniel, Alex S. Cohen, Philip D. Harvey, et al.
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
David G. Daniel, Alex S. Cohen, Philip D. Harvey, et al.
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
The Effects of Cognitive Remediation on Negative Symptoms in Schizophrenia-Spectrum Illness: A Meta-analytic Investigation of Efficacy
Grace Melville, Clara Preisig, Mei C. Zheng, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
Grace Melville, Clara Preisig, Mei C. Zheng, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
